|Becton, Dickinson and Co. (BD), of Franklin Lakes, N.J.||BD Veritor system for rapid detection of SARS-CoV-2 & Flu A+B||Rapid antigen test||Detects SARS-CoV-2, influenza A and influenza B in a single test||Received emergency use authorization from the U.S. FDA|
|Binx Health Inc., of Boston||Binx IO system||Molecular point-of-care testing platform||Detection of chlamydia and gonorrhea||FDA granted CLIA waiver; had previously received 510(k) clearance for use in moderate and high-complexity locations|
|Gold Standard Diagnostics Group, of Davis, Calif.||Borrelia burgdorferi IgG/IgM Vise-Ospc EIA test||Enzyme immunoassay (EIA) that can be used in the the CDC recommended modified two-tiered testing algorithm||Diagnosis of Lyme disease||Received U.S. FDA clearance|
|Nines Inc., of Palo Alto, Calif.||Ninesmeasure||Artificial intelligence-based tool||Helps radiologists to quickly measure the long and short axes of selected nodules in lung scans||Received 510(k) clearance from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.